The endocannabinoid (eCB) system participates in behavioral adaptations that accompany chronic exposure to opiates;the cellular bases for these changes are not known. One form of eCB signaling involves the postsynaptic production of eCBs that diffuse in a retrograde manner to act on presynaptic CB1 receptors to inhibit neurotransmitter release. In the prior funding period a cell culture model that displays robust eCBmediated depolarization-induced suppression of excitatory synaptic transmission (DSE) was developed. Preliminary data show that this model is well suited for examining adaptive changes in retrograde eCB signaling between hippocampal neurons.
Three specific aims will examine the effects of prolonged exposure to opiates on the eCB system. 1) Opiates exert marked effects on synaptic transmission between hippocampal neurons. The hypothesis that prolonged exposure to opiates will up-regulate eCB signaling will be tested. 2) Chronic exposure to opiate agonists increases the expression of brain derived neurotrophic factor (BDNF) and increases excitatory synaptic transmission. The hypothesis that BDNF and intense synaptic activity will produce a long-lasting strengthening of the eCB system will be tested. 3) CB1 antagonists show promise for the treatment of opiate addiction. How prolonged CB1 receptor blockade affects the function of the eCB system is not known. The hypothesis that removal of a CB1 receptor antagonist following prolonged blockade of presynaptic CB1 receptors will result in enhanced endocannabinoid signaling will be tested. Overall, these studies will provide insight into whether the pre- and post-synaptic elements of the eCB system change in parallel during exposure to and withdrawal from opiates. Understanding the plasticity of the system as a whole will aid in developing agents to modulate eCB signaling during withdrawal and abstinence from opiates.
|Hwang, Cheol Kyu; Wagley, Yadav; Law, Ping-Yee et al. (2017) Phosphorylation of poly(rC) binding protein 1 (PCBP1) contributes to stabilization of mu opioid receptor (MOR) mRNA via interaction with AU-rich element RNA-binding protein 1 (AUF1) and poly A binding protein (PABP). Gene 598:113-130|
|Kibaly, Cherkaouia; Lin, Hong-Yiou; Loh, Horace H et al. (2017) Spinal or supraspinal phosphorylation deficiency at the MOR C-terminus does not affect morphine tolerance in vivo. Pharmacol Res 119:153-168|
|Kibaly, Cherkaouia; Kam, Angel Y F; Loh, Horace H et al. (2016) Naltrexone Facilitates Learning and Delays Extinction by Increasing AMPA Receptor Phosphorylation and Membrane Insertion. Biol Psychiatry 79:906-16|
|Meng, Jingjing; Roy, Sabita (2016) Study of Epithelium Barrier Functions by Real-time TER Measurement. Bio Protoc 6:|
|Banerjee, S; Sindberg, G; Wang, F et al. (2016) Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation. Mucosal Immunol 9:1418-1428|
|Kotecki, Lydia; Hearing, Matthew; McCall, Nora M et al. (2015) GIRK Channels Modulate Opioid-Induced Motor Activity in a Cell Type- and Subunit-Dependent Manner. J Neurosci 35:7131-42|
|Hwang, Cheol Kyu; Wagley, Yadav; Law, Ping-Yee et al. (2015) Analysis of epigenetic mechanisms regulating opioid receptor gene transcription. Methods Mol Biol 1230:39-51|
|Wang, Yan; Ge, Yan-Hui; Wang, Yan-Xia et al. (2015) Modulation of mTOR Activity by ?-Opioid Receptor is Dependent upon the Association of Receptor and FK506-Binding Protein 12. CNS Neurosci Ther 21:591-8|
|Banerjee, Santanu; Ninkovic, Jana; Meng, Jingjing et al. (2015) Morphine compromises bronchial epithelial TLR2/IL17R signaling crosstalk, necessary for lung IL17 homeostasis. Sci Rep 5:11384|
|Wang, Yan; Wang, Yan-Xia; Liu, Ting et al. (2015) ?-Opioid receptor attenuates A? oligomers-induced neurotoxicity through mTOR signaling. CNS Neurosci Ther 21:8-14|
Showing the most recent 10 out of 308 publications